Veeral Desai - 14 Sep 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Chief Strategy & Dev. Officer
Signature: /s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 14 Sep 2021
Net transactions value: -$3,385,608
Form type: 4
Filing time: 15 Sep 2021, 17:18:10 UTC
Next filing: 18 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Options Exercise	$121,001	+121,001	+46%	$1.00^*	382,957	14 Sep 2021	Direct	F1
transaction	AGL	Common Stock	Sale	$3,506,609	-121,001	-32%	$28.98	261,956	14 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Rights to Buy)	Options Exercise	$0	-121,001	-10%	$0.000000	1,078,999	14 Sep 2021	Common Stock	121,001	$1.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted stock units.
F2	These options were granted on April 27, 2017, and fully vested on April 24, 2021.